BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25350456)

  • 1. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
    Calik MW; Carley DW
    PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats.
    Calik MW; Carley DW
    J Negat Results Biomed; 2016 May; 15():8. PubMed ID: 27133202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat.
    Calik MW; Radulovacki M; Carley DW
    Respir Physiol Neurobiol; 2014 Jan; 190():20-4. PubMed ID: 24121138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMSO potentiates the suppressive effect of dronabinol on sleep apnea and REM sleep in rats.
    Calik MW; Carley DW
    J Cannabis Res; 2023 Jul; 5(1):30. PubMed ID: 37507813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB
    Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
    Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
    Bagüés A; Martín MI; Sánchez-Robles EM
    Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents.
    Yeh CM; Ruan T; Lin YJ; Hsu TH
    Pulm Pharmacol Ther; 2016 Oct; 40():22-9. PubMed ID: 27328978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation.
    Wong H; Hossain S; Cairns BE
    Eur J Pain; 2017 Nov; 21(10):1732-1742. PubMed ID: 28722246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
    Franklin JM; Carrasco GA
    Synapse; 2013 Mar; 67(3):145-59. PubMed ID: 23151877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation and Upregulation of CB1 and CB2 Receptors.
    Jing N; Fang B; Wang ZL; Ma H
    Cell Physiol Biochem; 2017; 43(6):2516-2524. PubMed ID: 29130941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
    Bi GH; Galaj E; He Y; Xi ZX
    Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists.
    Altun A; Yildirim K; Ozdemir E; Bagcivan I; Gursoy S; Durmus N
    J Physiol Sci; 2015 Sep; 65(5):407-15. PubMed ID: 25894754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; Li C; Vadivel SK; Makriyannis A
    Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.
    Chin CL; Tovcimak AE; Hradil VP; Seifert TR; Hollingsworth PR; Chandran P; Zhu CZ; Gauvin D; Pai M; Wetter J; Hsieh GC; Honore P; Frost JM; Dart MJ; Meyer MD; Yao BB; Cox BF; Fox GB
    Br J Pharmacol; 2008 Jan; 153(2):367-79. PubMed ID: 17965748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
    Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
    Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.
    Franklin JM; Carrasco GA
    J Psychopharmacol; 2012 Oct; 26(10):1333-47. PubMed ID: 22791651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.